174 related articles for article (PubMed ID: 9154279)
1. Effects of exogenous prostaglandins on aqueous humor dynamics and blood-aqueous barrier function.
Toris CB; Camras CB; Yablonski ME; Brubaker RF
Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S69-75. PubMed ID: 9154279
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin A2 increases uveoscleral outflow and trabecular outflow facility in the cat.
Toris CB; Yablonski ME; Wang YL; Hayashi M
Exp Eye Res; 1995 Dec; 61(6):649-57. PubMed ID: 8846836
[TBL] [Abstract][Full Text] [Related]
3. Effect of topical prostaglandin D2 on the aqueous humor dynamics in rabbits.
Goh Y; Araie M; Nakajima M; Azuma I; Hayaishi O
Graefes Arch Clin Exp Ophthalmol; 1989; 227(5):476-81. PubMed ID: 2478423
[TBL] [Abstract][Full Text] [Related]
4. The effect of prostaglandin F2 alpha-1-isopropylester (PGF2 alpha-IE) on uveoscleral outflow.
Nilsson SF; Sperber GO; Bill A
Prog Clin Biol Res; 1989; 312():429-36. PubMed ID: 2678148
[TBL] [Abstract][Full Text] [Related]
5. The uveoscleral outflow routes.
Nilsson SF
Eye (Lond); 1997; 11 ( Pt 2)():149-54. PubMed ID: 9349404
[TBL] [Abstract][Full Text] [Related]
6. Initial clinical studies with prostaglandins and their analogues.
Camras CB; Alm A
Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S61-8. PubMed ID: 9154278
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin F2 alpha and its analogs induce release of endogenous prostaglandins in iris and ciliary muscles isolated from cat and other mammalian species.
Yousufzai SY; Ye Z; Abdel-Latif AA
Exp Eye Res; 1996 Sep; 63(3):305-10. PubMed ID: 8943703
[TBL] [Abstract][Full Text] [Related]
8. Effects of PhXA41, a new prostaglandin F2 alpha analog, on aqueous humor dynamics in human eyes.
Toris CB; Camras CB; Yablonski ME
Ophthalmology; 1993 Sep; 100(9):1297-304. PubMed ID: 8371915
[TBL] [Abstract][Full Text] [Related]
9. Eicosanoids as a new class of ocular hypotensive agents. 2. Comparison of the apparent mechanism of the ocular hypotensive effects of A and F type prostaglandins.
Hayashi M; Yablonski ME; Bito LZ
Invest Ophthalmol Vis Sci; 1987 Oct; 28(10):1639-43. PubMed ID: 3654137
[TBL] [Abstract][Full Text] [Related]
10. The effect of topical PGF2 alpha on uveoscleral outflow and outflow facility in the rabbit eye.
Poyer JF; Gabelt B; Kaufman PL
Exp Eye Res; 1992 Feb; 54(2):277-83. PubMed ID: 1559555
[TBL] [Abstract][Full Text] [Related]
11. Effects of topical nipradilol, a beta-blocking agent with alpha-blocking and nitroglycerin-like activities, on aqueous humor dynamics and fundus circulation.
Kanno M; Araie M; Tomita K; Sawanobori K
Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):736-43. PubMed ID: 9538880
[TBL] [Abstract][Full Text] [Related]
12. Microvascular effects of selective prostaglandin analogues in the eye with special reference to latanoprost and glaucoma treatment.
Stjernschantz J; Selén G; Astin M; Resul B
Prog Retin Eye Res; 2000 Jul; 19(4):459-96. PubMed ID: 10785618
[TBL] [Abstract][Full Text] [Related]
13. The effects of prostaglandins on the blood-ocular barrier.
Kosaka T; Mishima HK; Kiuchi Y; Kataoka K
Jpn J Ophthalmol; 1995; 39(4):368-76. PubMed ID: 8926644
[TBL] [Abstract][Full Text] [Related]
14. Effects of prostaglandins on the aqueous humor outflow pathways.
Weinreb RN; Toris CB; Gabelt BT; Lindsey JD; Kaufman PL
Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S53-64. PubMed ID: 12204701
[TBL] [Abstract][Full Text] [Related]
15. The influence of Latanoprost 0.005% on aqueous humor flow and outflow facility in glaucoma patients: a double-masked placebo-controlled clinical study.
Dinslage S; Hueber A; Diestelhorst M; Krieglstein G
Graefes Arch Clin Exp Ophthalmol; 2004 Aug; 242(8):654-60. PubMed ID: 15241610
[TBL] [Abstract][Full Text] [Related]
16. Effects of topical PGF2 alpha on aqueous humor dynamics in cynomolgus monkeys.
Crawford K; Kaufman PL; Gabelt BT
Curr Eye Res; 1987 Aug; 6(8):1035-44. PubMed ID: 3478175
[TBL] [Abstract][Full Text] [Related]
17. Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F2 alpha-1-isopropylester in the cynomolgus monkey.
Nilsson SF; Samuelsson M; Bill A; Stjernschantz J
Exp Eye Res; 1989 May; 48(5):707-16. PubMed ID: 2737263
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and mechanisms of intraocular pressure reduction with latanoprost and timolol in participants with ocular hypertension: a comparison of 1 and 6 weeks of treatment.
Johnson TV; Fan S; Zhan G; Camras CB; Toris CB
J Glaucoma; 2010 Aug; 19(6):356-64. PubMed ID: 20179619
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacological profiles of latanoprost (Xalatan), a novel anti-glaucoma drug].
Nomura S; Hashimoto M
Nihon Yakurigaku Zasshi; 2000 May; 115(5):280-6. PubMed ID: 10872179
[TBL] [Abstract][Full Text] [Related]
20. The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes.
Ziai N; Dolan JW; Kacere RD; Brubaker RF
Arch Ophthalmol; 1993 Oct; 111(10):1351-8. PubMed ID: 8216015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
